Detailed information for compound 1504974

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 335.271 | Formula: C18H20Cl2N2
  • H donors: 1 H acceptors: 1 LogP: 4.9 Rotable bonds: 1 Rule of 5 violations (Lipinski): 1
  • SMILES: CCC1=C[C@H]2C[C@@H](C1)c1c(C2)nc2c(c1N)ccc(c2)Cl.Cl
  • InChi: 1S/C18H19ClN2.ClH/c1-2-10-5-11-7-12(6-10)17-16(8-11)21-15-9-13(19)3-4-14(15)18(17)20;/h3-5,9,11-12H,2,6-8H2,1H3,(H2,20,21);1H/t11-,12+;/m0./s1


Hover on a compound node to display the structore


No synonyms found for this compound


Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species


Activity type Activity value Assay description Source Reference
Activity (functional) = 40 % Antialzheimer activity in transgenic mouse harboring K670M/N671L, PS1M146V and tauP301L mutants assessed as reduction in hippocampal Abeta(1-40) levels at 0.12 umol/kg, ip for 21 days by ELISA ChEMBL. 22185619
IC50 (functional) = 300 nM Antitrypanosomal activity against Trypanosoma brucei 427 ChEMBL. 21315611
IC50 (functional) = 0.84 uM Trypanocidal activity against bloodstream form of Trypanosoma brucei 427 after 48 hrs ChEMBL. 21315611
IC90 (functional) = 1.76 uM Trypanocidal activity against bloodstream form of Trypanosoma brucei 427 after 48 hrs ChEMBL. 21315611


Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Trypanosoma brucei gambiense 21315611
Trypanosoma brucei ChEMBL23 21315611

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.